Literature DB >> 3207103

Exposure to organic solvents and hypertensive disorders of pregnancy.

B Eskenazi1, M B Bracken, T R Holford, J Grady.   

Abstract

The present investigation compares the frequency of adverse pregnancy complications and outcomes in 90 women who worked with various organic solvents during pregnancy and in 180 unexposed matched (2:1) subjects. Solvent-exposed women were approximately four times more likely to develop preeclampsia, a disorder of pregnancy characterized by hypertension, edema, and proteinuria (unconditional adjusted RR = 3.9, 95% CI = 2.5, 5.4). That hypertension alone, without edema or proteinuria, was also more likely to be reported in solvent-exposed women (unconditional adjusted RR = 3.0, 95% CI = 0.9, 9.9) lent additional support to the association of solvent exposure and hypertensive disorders of pregnancy. Because preeclampsia is thought to be associated primarily with glomerular lesions, our findings, although in need of replication with a larger sample size, may be biologically plausible given the growing literature associating solvent exposure with renal disease. Solvent-exposed women were more likely to have cardiovascular complications and to deliver by cesarean section; however, given the specific type of complications and reason for cesarean, it is unlikely that these findings were directly related to solvent exposure. Other pregnancy complications such as threatened abortion and vaginal bleeding, and poor neonatal growth and maturity, were not more common in the exposed group.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207103     DOI: 10.1002/ajim.4700140208

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  7 in total

1.  Chronic exposure to e-cig aerosols during early development causes vascular dysfunction and offspring growth deficits.

Authors:  Marcus R Orzabal; Emilie R Lunde-Young; Josue I Ramirez; Selene Y F Howe; Vishal D Naik; Jehoon Lee; Cristine L Heaps; David W Threadgill; Jayanth Ramadoss
Journal:  Transl Res       Date:  2019-01-07       Impact factor: 7.012

2.  Pregnancy-induced hypertension in North Carolina, 1988 and 1989.

Authors:  D A Savitz; J Zhang
Journal:  Am J Public Health       Date:  1992-05       Impact factor: 9.308

3.  Investigating geographic differences in environmental chemical exposures in maternal and cord sera using non-targeted screening and silicone wristbands in California.

Authors:  Dana E Goin; Dimitri Abrahamsson; Miaomiao Wang; June-Soo Park; Marina Sirota; Rachel Morello-Frosch; Erin DeMicco; Jessica Trowbridge; Laura August; Steven O'Connell; Subhashini Ladella; Marya G Zlatnik; Tracey J Woodruff
Journal:  J Expo Sci Environ Epidemiol       Date:  2022-04-21       Impact factor: 6.371

4.  Results of common laboratory tests in solvent-exposed workers.

Authors:  Ari Kaukiainen; Tapio Vehmas; Kaarina Rantala; Markku Nurminen; Rami Martikainen; Helena Taskinen
Journal:  Int Arch Occup Environ Health       Date:  2003-11-05       Impact factor: 3.015

5.  Work-related maternal risk factors and the risk of pregnancy induced hypertension and preeclampsia during pregnancy. The Generation R Study.

Authors:  Jaap Jan Nugteren; Claudia A Snijder; Albert Hofman; Vincent W V Jaddoe; Eric A P Steegers; Alex Burdorf
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

6.  Pesticide exposure and hypertensive disorders during pregnancy.

Authors:  Tina M Saldana; Olga Basso; Donna D Baird; Jane A Hoppin; Clarice R Weinberg; Aaron Blair; Michael C R Alavanja; Dale P Sandler
Journal:  Environ Health Perspect       Date:  2009-06-04       Impact factor: 9.031

7.  Environmental Factors Involved in Maternal Morbidity and Mortality.

Authors:  Abee L Boyles; Brandiese E Beverly; Suzanne E Fenton; Chandra L Jackson; Anne Marie Z Jukic; Vicki L Sutherland; Donna D Baird; Gwen W Collman; Darlene Dixon; Kelly K Ferguson; Janet E Hall; Elizabeth M Martin; Thaddeus T Schug; Alexandra J White; Kelly J Chandler
Journal:  J Womens Health (Larchmt)       Date:  2020-11-18       Impact factor: 2.681

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.